chr7-100057866-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145914.3(ZSCAN21):c.568G>A(p.Ala190Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,609,982 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_145914.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZSCAN21 | NM_145914.3 | c.568G>A | p.Ala190Thr | missense_variant | 3/4 | ENST00000292450.9 | NP_666019.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZSCAN21 | ENST00000292450.9 | c.568G>A | p.Ala190Thr | missense_variant | 3/4 | 1 | NM_145914.3 | ENSP00000292450.4 | ||
ZSCAN21 | ENST00000456748.6 | c.568G>A | p.Ala190Thr | missense_variant | 3/5 | 5 | ENSP00000390960.2 | |||
ZSCAN21 | ENST00000477297.1 | n.664G>A | non_coding_transcript_exon_variant | 2/3 | 3 | |||||
ZSCAN21 | ENST00000438937.1 | c.*25G>A | downstream_gene_variant | 2 | ENSP00000404207.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152152Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000526 AC: 13AN: 246988Hom.: 1 AF XY: 0.0000599 AC XY: 8AN XY: 133662
GnomAD4 exome AF: 0.0000220 AC: 32AN: 1457712Hom.: 1 Cov.: 31 AF XY: 0.0000303 AC XY: 22AN XY: 725192
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152270Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74456
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 28, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at